Bottom line
How much do PHSYX and GGHCX overlap?
57% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 56.2% of PHSYX's assets and 45.5% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHSYX and GGHCX have in common
| Holding | % of PHSYX | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 13.15% | 10.59% | 10.59% |
| Johnson & Johnson | 8.46% | 6.76% | 6.76% |
| UnitedHealth Group, Inc. | 6.93% | 6.17% | 6.17% |
| AbbVie, Inc. | 6.05% | 4.03% | 4.03% |
| Merck & Co., Inc. | 4.88% | 4.59% | 4.59% |
| Thermo Fisher Scientific, Inc. | 4.50% | 1.55% | 1.55% |
| Edwards Lifesciences Corp. | 2.80% | 1.56% | 1.56% |
| CVS Health Corp. | 2.74% | 2.52% | 2.52% |
| Gilead Sciences, Inc. | 2.63% | 3.63% | 2.63% |
| Cardinal Health, Inc. | 2.12% | 2.10% | 2.10% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.01% | 1.97% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHSYX
- Novartis AG — 5.13%
- AstraZeneca plc — 4.67%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
- Roche Holding AG — 2.79%
- McKesson Corp. — 2.14%
- Novo Nordisk A/S — 1.90%
- Boston Scientific Corp. — 1.80%
- Bristol-Myers Squibb Co. — 1.75%
- Dexcom, Inc. — 1.64%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
- HCA Healthcare, Inc. — 1.18%
- Amgen, Inc. — 1.11%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | PHSYX | GGHCX |
|---|---|---|
| Stocks | 98.2% | 97.5% |
| Cash & short-term funds | 0.6% | 8.8% |
| Other | 1.4% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | PHSYX | GGHCX |
|---|---|---|
| US | 76.2% | 93.5% |
| CH | 7.9% | 2.7% |
| GB | 6.4% | 3.1% |
| NL | 1.2% | 3.4% |
| FR | 3.2% | — |
| DK | 2.4% | 1.1% |
| JP | 2.4% | — |
| BE | — | 1.2% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PHSYX and GGHCX overlap?
What stocks do PHSYX and GGHCX have in common?
Should I own both PHSYX and GGHCX?
Which holds more stocks, PHSYX or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.